Status:
RECRUITING
Impact on the Absorption of Drugs in Ostomy Patients
Lead Sponsor:
WiGeV Klinik Ottakring
Conditions:
Stoma Ileostomy
Ileostomy - Stoma
Eligibility:
All Genders
18+ years
Brief Summary
Peroral administration is the preferred way of taking medication. However, the special absorption conditions in ostomy patients are generally not addressed in approval studies and there is also little...
Eligibility Criteria
Inclusion
- Planned inclusion criteria:
- Male and female patients aged ≥18 years
- Belonging to a collective
- Ileostomy since ≥7d
- Colostomy since ≥7d The stoma must have been inserted at least 7d ago to ensure that a steady state concentration is achieved.
- Taking ≥1 of the following active substances since ≥7d:
- Psychotropic drugs: citalopram, clozapine, duloxetine, escitalopram, melperone, mianserin, milnacipran, mirtazapine, olanzapine, paliperidone, paroxetine, pregabalin, prothipendyl, quetiapine, risperidone, sertraline, trazodone, venlafaxine
- NOACs: edoxaban, rivaroxban, apixaban
- Exclusion Criteria:
- Insurmountable language barrier
Exclusion
Key Trial Info
Start Date :
June 18 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT07138326
Start Date
June 18 2025
End Date
December 31 2026
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
WiGeV Klinik Ottakring
Vienna, Vienna, Austria, 1160